Home/OrSense/Yoav Reisman
YR

Yoav Reisman

Chief Executive Officer

OrSense

Therapeutic Areas

OrSense Pipeline

DrugIndicationPhase
NBM 200Hemoglobin & Oxygen Saturation MeasurementApproved
SOLISSoftware/Inventory Management SystemCommercial